And the volume was pretty yest, even if price didn't move much. I am trying to understand why anyone would buy or sell Response based on that PR which was as devoid of meaningful details as any PR could be. I almost feel the company need not have bothered to put out the PR.
Did anyone listen to the conf call for analysts yesterday or otherwise learn any details of the deal with Roche?
News 
Market Data 
Discover 
